Otc - Purpose
Oral Homeopathic Medicine
50 doses, each 1 mL
(.03 fl oz)
Pleo Ut S
FDA Label NDC 60681-5407
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Sanum Kehlbeck Gmbh & Co. Kg for the product Pleo Ut S (NDC 60681-5407). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding otc - purpose, indications, directions for use, dosage, warning, tamper evident, other, principal display panel - 1 ml carton, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Indications
For temporary relief of flu symptoms.
Directions For Use
Snap off top portion of sipping container. Insert glass sipping straw.
Dosage
1–2 × weekly 1 sip.
Warning
If symptoms persist more than a few days, contact a licensed practitioner. As with any drug, if you are pregnant or nursing a baby, seek the advice of a health care professional before using this product.
Tamper Evident
Do not use this product if the glass vial is broken.
Other
Manufactured by:
Sanum-Kehlbeck GmbH & Co. KG,
Hoya, Germany
Distributed by:
SANUM USA Corp.,
1465 Slater Road,
Ferndale, WA 98248
Rev. 12/2011
Principal Display Panel - 1 Ml Carton
5407-1
Pleo® Ut "S"
PORTABLE SIPS 6X
Oral Homeopathic Medicine
The original
SANUM®
brand remedies
INDICATIONS: For temporary relief of flu
symptoms.
DIRECTIONS FOR USE: Snap off top
portion of sipping container. Insert glass
sipping straw.
DOSAGE: 1–2 x weekly 1 sip.
INGREDIENTS: 1 mL contains Myco-
bacterium phlei 6X, in a base of purified
saline solution.
Tamper Evident: Do not use this product
if the glass vial is broken.
convenient, disposable
single dose containers
10 doses, each 1 mL
(.03 fl oz)
Rev. 12/2011
Principal Display Panel (1 mL Carton)
* Please review the disclaimer below.
